Jennifer L. Taubert - 10 Feb 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WWC. Innovative Medicine
Signature
/s/ Laura H. McFalls, as attorney-in-fact for Jennifer Taubert
Issuer symbol
JNJ
Transactions as of
10 Feb 2025
Net transactions value
$0
Form type
4
Filing time
12 Feb 2025, 18:18:00 UTC
Previous filing
11 Feb 2025
Next filing
18 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Performance Share Units Award $0 +15,465 $0.000000 15,465 10 Feb 2025 Common Stock 15,465 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.
F2 The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement.